Provention Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Provention Bio and other ETFs, options, and stocks.

About PRVB

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. 

CEO
Ashleigh W. Palmer
CEOAshleigh W. Palmer
Employees
82
Employees82
Headquarters
Red Bank, New Jersey
HeadquartersRed Bank, New Jersey
Founded
2016
Founded2016
Employees
82
Employees82

PRVB Key Statistics

Market cap
366.97M
Market cap366.97M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
542.45K
Average volume542.45K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$8.04
52 Week high$8.04
52 Week low
$3.19
52 Week low$3.19

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

PRVB Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.